Compare ONCY & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONCY | ARAY |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.0M | 100.5M |
| IPO Year | 1999 | 2007 |
| Metric | ONCY | ARAY |
|---|---|---|
| Price | $1.12 | $0.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $6.00 | $4.50 |
| AVG Volume (30 Days) | ★ 1.2M | 719.5K |
| Earning Date | 03-06-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $450,902,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | N/A | $4.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.51 |
| 52 Week Low | $0.33 | $0.78 |
| 52 Week High | $1.51 | $2.95 |
| Indicator | ONCY | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 35.93 |
| Support Level | $0.98 | $0.79 |
| Resistance Level | $1.30 | $0.86 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 52.63 | 3.67 |
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.